Clinical Trials Directory

Trials / Completed

CompletedNCT05253937

Impact of Intracoronary Versus Intravenous Epinephrine Administration During Cardiac Arrest .

Impact of Intracoronary Versus Central and Peripheral Intravenous Epinephrine Administration During Cardiac Arrest in The Cardiac Catheterization Laboratory for Acute Myocardial Infarction Patients.

Status
Completed
Phase
Study type
Observational
Enrollment
160 (actual)
Sponsor
Lithuanian University of Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

In hospital cardiac arrest (IHCA) is a major challenge imposed on almost all health care systems worldwide. Despite significant progress in cardiopulmonary resuscitation in the past few years, outcomes remain relatively poor with an approximate 49 % survival rate. Epinephrine administration remains a cornerstone in the treatment of cardiac arrest. However, the preferred route of administration remains a matter of debate within the medical community . Various routes of administration, including intravenous, intramuscular, intraosseous and endotracheal routes have been studied. Initially, American guidelines for the treatment of cardiac arrest recommended injection of 0.5 mg of epinephrine directly into the right ventricle through the parasternal approach, aiming to achieve higher peak intracardiac concentrations and a more central effect, however the intravenous route remained preferable due to its feasibility and safety . To our knowledge, intra-coronary epinephrine administration for intraprocedural cardiac arrest has not been evaluated or compared with other routes of administration.

Conditions

Interventions

TypeNameDescription
DRUGEpinephrinThe study will enroll acute myocardial infarction patients who suffered from a cardiac arrest in the cardiac catheterization laboratory during percutaneous intervention procedure. Cardiac Resuscitation was performed according to the European Resuscitation Council (ERC) Guidelines. The preferred route of epinephrine administration was through the central venous access (by internal jugular or subclavian vein). Thus, if available, it was the preferred method of medication delivery. However, in cases without central venous access, the route of epinephrine administration (peripheral intravenous or arterial intracoronary) during cardiac arrest was left to the treating physicians.

Timeline

Start date
2018-04-01
Primary completion
2021-06-01
Completion
2022-06-01
First posted
2022-02-24
Last updated
2022-08-16

Locations

1 site across 1 country: Lithuania

Source: ClinicalTrials.gov record NCT05253937. Inclusion in this directory is not an endorsement.